Harnessing the microbiome to treat skin disease

cubes-home

Our Approach

Azitra Inc. is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases. The Company’s technology platform, developed in collaboration with scientists at Yale University and the Jackson Laboratory, is based on a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis. Direct application of these commensal bacteria alone improves skin appearance, hydration, and healing. These bacteria can also be designed to become effective therapies using the tools of genetic engineering. Many diseases, including ichthyosis vulgaris and orphan diseases such as Netherton syndrome, are the result of deficient or missing proteins in the skin. We have engineered commensal skin bacteria to deliver these missing, critical proteins directly to the target through the stratum corneum of the skin, resolving the underlying disease cause and returning the microbiome to a more normal state. This approach represents a major platform technology adaptable to the expression of different proteins that target multiple diseases and skin care needs. These types of products, known as Live Biotherapeutic Products (LBPs), are cost-effective topical applications with the potential to solve skin disease challenges and avoid systemic therapy. Azitra has pioneered this work and established many of the foundation patents in the space. Our products are rapidly progressing to clinical testing and commercialization.

Driven Leadership

Our Leadership Team

Richard Andrews
pipebar

Richard Andrews, SM, MS

President and CEO

pipebar

Jeanne Bertonis

Chief Operating Officer

pipebar

Gilles Dube, PhD

Sr. Director Product Development

pipebar

Trudy H. Grossman, Ph.D.

Vice President of Research

pipebar

Roger Leger, PhD

Vice President of Chemistry, Formulation and Development

pipebar

Mark Sampson

Chief Scientific Officer

pipebar

Travis Whitfill, MPH

Co-founder and Executive Director of Advanced Technology

Board of Directors

pipebar

Richard Andrews, SM, MS

President and CEO

pipebar

Cain McClary, MD

Founder and Managing Partner
KdT Ventures

pipebar

Stella M. Roberston, PhD

Partner, Bios Partners

pipebar

Travis Whitfill, MPH

Co-Founder and CSO

Scientific Advisory Board

pipebar

Travis Whitfill, MPH

Co-founder and Executive Director of Advanced Technology, Chair of Scientific Advisory Board

pipebar

Jeffrey L. Bose, Ph.D.

Assistant Professor, University of Kansas Medical Center

pipebar

Leonard Milstone, MD

Professor Emeritus of Dermatology at Yale Medical School

pipebar

Julia Oh, PhD

Assistant Professor at The Jackson Laboratory for Genomic Medicine

Investors

Additional Support

Top